February 3, 2021 Quanterix Announces Proposed Public Offering of $200.0 Million of its Common Stock read more
January 11, 2021 Quanterix Receives FDA Emergency Use Authorization for SARS-CoV-2 N Protein Antigen Test read more
January 6, 2021 Quanterix Corporation to Present At 39th Annual J.P. Morgan Healthcare Conference read more
December 29, 2020 Quanterix Receives FDA Emergency Use Authorization for Semi-Quantitative Antibody Test read more
November 13, 2020 Quanterix To Participate In The Canaccord Medical Technologies And Diagnostics Forum read more